One of the challenging concepts in understanding the role of ACE2 is that while tissue ACE2 is a negative regulator of RAS, and thus a protective marker against thrombosis and atherosclerosis, high risk patients have demonstrated conversely higher circulating ACE2 levels [3,6]. Here, ACE2 is linked to atherosclerosis.